PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
62.39%
Net income growth above 1.5x AVGO's 22.20%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
No Data
No Data available this quarter, please select a different quarter.
46.67%
Some yoy growth while AVGO is negative at -149.14%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
702.00%
Well above AVGO's 54.39% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
132.92%
AR growth well above AVGO's 23.18%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
-32.00%
Both reduce yoy inventory, with AVGO at -1180.00%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
74.36%
A yoy AP increase while AVGO is negative at -152.79%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
-89.39%
Negative yoy usage while AVGO is 299.52%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
33.33%
Some yoy increase while AVGO is negative at -68.85%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
75.21%
Some CFO growth while AVGO is negative at -1.09%. John Neff would note a short-term liquidity lead over the competitor.
8.85%
Lower CapEx growth vs. AVGO's 29.05%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
99.52%
Purchases growth of 99.52% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-69.70%
We reduce yoy sales while AVGO is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-62.85%
We reduce yoy other investing while AVGO is 175.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-64.57%
Both yoy lines negative, with AVGO at -291.67%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-304.00%
We cut yoy buybacks while AVGO is 12.33%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.